AstraZeneca buys 55 per cent stake in Acerta for $4 billion
Deal gives drugmaker a late-stage medicine to treat patients for a range of blood cancers
AstraZeneca confirms talks with Dutch firm Acerta Pharma
British drugmaker said to looking to acquire Acerta for more than $5 billion
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices